admin
Acquiring a pharmaceutical business can accelerate growth through ready licences, product registrations and manufacturing capacity. It also carries risks that only specialised due diligence will uncover.
Regulatory Due Diligence
- Validity of manufacturing licences and product permissions
- Inspection history, observations and CAPA status
- Status of product registrations in export markets
Technical and Quality Review
Assess the condition of facilities, equipment and utilities, as well as the maturity of the quality system and data integrity practices.
Commercial Assessment
- Revenue concentration by product, customer and market
- Pricing pressure and exposure to price controlled products
- Distribution agreements and change of control clauses
Integration Planning
Value is created after closing. Plan quality system harmonisation, people and culture integration, and portfolio rationalisation before the deal is signed.
Key takeaway
In pharma, regulatory and quality findings can change the value of a deal more than financial numbers. Include specialists from the start.
